<DOC>
	<DOC>NCT00544206</DOC>
	<brief_summary>To compare the glucose response in tube fed subjects with type 2 diabetes of a standard enteral product to that of a diabetes-specific enteral product</brief_summary>
	<brief_title>Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>signed and dated informed consent diagnosis of type 2 diabetes HbA1c between 7.0 and 9.0% 18 75 years of age currently receiving a standard enteral product anticipated duration on tube feeding at least one month 100% of patient's nutrient and energy needs are anticipated to be met by enteral nutrition support anticipated life expectancy is more than or equal to 6 months free of infections no change in medications within 2 weeks prior to screening that could profoundly affect blood glucose composition of either product is inappropriate for the patient due to allergies or intolerance to any ingredient found in the study products composition of either product is inappropriate for the patient due to protein, fluid or electrolyte restrictions for concomitant conditions significant cardiovascular event less than or equal to 2 weeks prior to study entry major surgery less than or equal to 2 weeks prior to study entry preplanned surgery during the study period active malignancy, including melanoma and excluding cutaneous malignancies severe dementia known allergies to medical grade adhesives and/or skin disinfectants taking octreotide chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV participation in a concomitant trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>